BioWorld Science https://www.bioworld.com/rss en-us Engitix seals GSK deal for targets to reverse liver fibrosis http://www.bioworld.com/articles/731798 Tue, 09 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731798-engitix-seals-gsk-deal-for-targets-to-reverse-liver-fibrosis Liver New 5-HT2C receptor agonists reported in Hansoh patent http://www.bioworld.com/articles/731773 Tue, 09 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731773-new-5-ht2c-receptor-agonists-reported-in-hansoh-patent Pheon Therapeutics discovers new CDCP1-targeting ADCs http://www.bioworld.com/articles/731772 Tue, 09 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731772-pheon-therapeutics-discovers-new-cdcp1-targeting-adcs Roche discloses new DGKA/DGKZ inhibitors http://www.bioworld.com/articles/731771 Tue, 09 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731771-roche-discloses-new-dgka-dgkz-inhibitors Eli Lilly identifies new GCGR agonists http://www.bioworld.com/articles/731770 Tue, 09 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731770-eli-lilly-identifies-new-gcgr-agonists Hubei Bio-Pharmaceutical synthesizes new PTPN1/PTPN2 inhibitors http://www.bioworld.com/articles/731769 Tue, 09 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731769-hubei-bio-pharmaceutical-synthesizes-new-ptpn1-ptpn2-inhibitors Grant supports Harness Therapeutics’ Parkinson’s disease program http://www.bioworld.com/articles/731765 Tue, 09 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731765-grant-supports-harness-therapeutics-parkinsons-disease-program Illustration depicting symptoms of Parkinson’s disease RBM39 degraders show efficacy in Ewing sarcoma tumors http://www.bioworld.com/articles/731764 Tue, 09 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731764-rbm39-degraders-show-efficacy-in-ewing-sarcoma-tumors Concept art for targeting cancer Gen1e Lifesciences receives US FDA designations for GEn-1123 http://www.bioworld.com/articles/731763 Tue, 09 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731763-gen1e-lifesciences-receives-us-fda-designations-for-gen-1123 Art concept for inflamed human tissue City Therapeutics advances RNAi pipeline with series B financing http://www.bioworld.com/articles/731762 Tue, 09 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731762-city-therapeutics-advances-rnai-pipeline-with-series-b-financing Kymera’s KT-579 shows promise for SLE treatment http://www.bioworld.com/articles/731761 Tue, 09 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731761-kymeras-kt-579-shows-promise-for-sle-treatment Illustration of B cell releasing antibodies Moderna’s mRNA-4194 cleared for clinic for Lynch syndrome http://www.bioworld.com/articles/731760 Tue, 09 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731760-modernas-mrna-4194-cleared-for-clinic-for-lynch-syndrome Illustration of messenger RNA Flobiotech and UCLA Health partner in neurodegeneration http://www.bioworld.com/articles/731759 Tue, 09 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731759-flobiotech-and-ucla-health-partner-in-neurodegeneration Photo of researchers shaking hands CNTY-813 enables durable glucose control without immunosuppression need http://www.bioworld.com/articles/731758 Tue, 09 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731758-cnty-813-enables-durable-glucose-control-without-immunosuppression-need Illustration of pancreas, close up of islet Pre-disease plasma signature may help redefine lung cancer risk Cell, the study was a collaboration between the Francis Crick Institute and University College London. It was co-led by Walter and Eliza Hall Institute laboratory head Clare Weeden, who conducted the research while at the Crick.]]> http://www.bioworld.com/articles/731757 Tue, 09 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731757-pre-disease-plasma-signature-may-help-redefine-lung-cancer-risk Blood sample tubes after centrifuge Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors http://www.bioworld.com/articles/731753 Mon, 08 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731753-empire-discovery-institute-univ-of-rochester-identify-irak-inhibitors Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors http://www.bioworld.com/articles/731752 Mon, 08 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731752-antares-therapeutics-divulges-new-cdk2-cyclin-e1-inhibitors Eikon Therapeutics discloses new USP1 inhibitors http://www.bioworld.com/articles/731751 Mon, 08 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731751-eikon-therapeutics-discloses-new-usp1-inhibitors U.S. researchers report new antimalarial compounds http://www.bioworld.com/articles/731750 Mon, 08 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731750-us-researchers-report-new-antimalarial-compounds Onkure Therapeutics patents new PI3Kα mutant inhibitors http://www.bioworld.com/articles/731749 Mon, 08 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731749-onkure-therapeutics-patents-new-pi3k-mutant-inhibitors Dual ABCB4/ABCB11 modulation shows promise in cholestatic disease models http://www.bioworld.com/articles/731744 Mon, 08 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731744-dual-abcb4-abcb11-modulation-shows-promise-in-cholestatic-disease-models Liver anatomy illustration LBL-051: Broad immune targeting in autoimmune disease http://www.bioworld.com/articles/731743 Mon, 08 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731743-lbl-051-broad-immune-targeting-in-autoimmune-disease Illustration of magnifying glass and antibodies ATG-207 shows efficacy in EAE with reduced cytokine release http://www.bioworld.com/articles/731742 Mon, 08 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731742-atg-207-shows-efficacy-in-eae-with-reduced-cytokine-release Illustration of lymphocytes China’s NMPA clears Hansoh’s HS-10541 for clinic http://www.bioworld.com/articles/731741 Mon, 08 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731741-chinas-nmpa-clears-hansohs-hs-10541-for-clinic Art concept for tumor Genescience presents data on Gensci-136, a dual BAFF/APRIL inhibitor for SLE http://www.bioworld.com/articles/731740 Mon, 08 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731740-genescience-presents-data-on-gensci-136-a-dual-baff-april-inhibitor-for-sle B-cell releasing antibodies Amphista’s BRD9 degrader gains IND clearance for AML http://www.bioworld.com/articles/731739 Mon, 08 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731739-amphistas-brd9-degrader-gains-ind-clearance-for-aml 3D illustration of acute myeloid leukemia cells CD39 mRNA-loaded nanoliposomes attenuate local acute inflammation http://www.bioworld.com/articles/731738 Mon, 08 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731738-cd39-mrna-loaded-nanoliposomes-attenuate-local-acute-inflammation Skape Bio unlocks GPCR targets with de novo-designed miniproteins http://www.bioworld.com/articles/731737 Mon, 08 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731737-skape-bio-unlocks-gpcr-targets-with-de-novo-designed-miniproteins 3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane. β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane. NME Digest: Q1 2026 http://www.bioworld.com/articles/731756 Fri, 05 Jun 2026 10:00:00 -0400 https://www.bioworld.com/articles/731756-nme-digest-q1-2026 Technique links non-coding mutations to disease genes they regulate http://www.bioworld.com/articles/731755 Fri, 05 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731755-technique-links-non-coding-mutations-to-disease-genes-they-regulate Gastrointestinal system with DNA, scientific background